Page 2444

(10) a drug that is

(A) prescribed by a provider who is not enrolled under 7 AAC 105.210; or

(B) not prescribed in accordance with 7 AAC 105.220(a), regardless of whether the drug would otherwise be covered. (Eff. 5/18/2014, Register 210; am 5/19/2023, Register 246; am 3/1/2024, Register 249) Statutory Authority: Authority: AS 47.05.010 AS 47.07.030 AS 47.07.040 7 AAC 120.114. Tamper-resistant prescription requirements. (a) If a covered outpatient drug under 7 AAC 120.110(b) and payable under Medicaid is not prescribed by electronic transmission in accordance with 12 AAC 52.490 or by verbal communication, the prescription for that drug must be submitted on tamper-resistant paper or on plain paper with tamper-resistant features generated through an electronic medical record practice system in order to be paid by the department. Each prescription form must contain the prescriber’s National Provider Identifier (NPI) number under 45 C.F.R. 162.402 — 162.414. (b) The requirements in (a) of this section do not apply to a

(1) prescription for which retroactive Medicaid eligibility has been determined under 7 AAC 100.072, except for refills that are filled after the retroactive eligibility determination date; or

(2) prescription prepared in an institutional pharmacy, if the prescriber writes the prescription into the medical record, the medical staff gives the order directly to the institutional pharmacy, and the patient does not handle or have the opportunity to handle the prescription; in this paragraph, “institutional pharmacy” has the meaning given in 12 AAC 52.995(a). (c) The tamper-resistant paper or tamper-resistant printing required under (a) of this section must include at least one industry-recognized feature designed to prevent unauthorized copying of a completed prescription, at least one industry-recognized feature designed to prevent the erasure or modification of information written on the prescription by the prescriber, and at least one industry-recognized feature designed to prevent the use of counterfeit prescription forms. Any one feature may not be used more than once for proof of tamper resistance. (d) Industry-recognized features designed to prevent unauthorized copying of a completed or blank prescription form include